PPT-Phase 2 of new ARVs

Fostemsavir prodrug of temsavir attachment inhibitor AI438011 Study TAF TFV prodrug Study 2920102 Study 2990102 Doravirine non nucleoside reverse transcriptase inhibitor. do not get rid of HIV from the body – they stop the production of . virus!. HIV IS A VIRUS.... HIV = virus. HIV virus. DEFENCE CELL. DEFENCE CELLS PROTECT US FROM DISEASES . . .. HIV virus. DEFENCE CELL. the Centers. for Disease Control and Prevention (CDC) under the terms of cooperative agreement #U2GGH000994. Its contents are solely the responsibility of the authors and do not necessarily represent the views of the U.S. Government.. Learning Objectives. Understand key counseling techniques. Learn and apply motivational interviewing tools to adherence counseling. Outline. Key Counseling Techniques . Therapeutic Alliance. Collaborative Health Education. What the Primary Care Provider Should Know. Carolyn K. Burr, . EdD. , RN. Co-Clinical Director NY/NJ AETC LPS. Deputy Director . François-Xavier Bagnoud Center. December 17. th. , 2013. Support for this program is provided in part through an educational training grant from the New Jersey Department of Health (NJDOH), Division of HIV,STD and TB Services.. Martina Penazzato MD, PhD. Paediatric lead, HIV Department. World Health Organization, Geneva. Background. 1.8 million children were estimated to live with HIV in 2017. In 2017, only 51 % of HIV-exposed infants received EID (by 2mo). . The GFATM procurement cliff. Sharonann Lynch. HIV & TB Policy Advisor. MSF Access Campaign. 1. 2. UNAIDS 2018. “There . were no new significant commitments from donors in 2017. . . The recent rise in donor funding is not expected to continue. U.S. . Public Health Service Guidelines for the Management of Occupational . Exposures . to HIV and Recommendations . for . Postexposure Prophylaxis. . Published August 2013. AETC NRC Slide Set. These slides were developed using the September 2013 updated guidelines on postexposure prophylaxis (PEP) following occupational exposure to HIV. The intended audience is clinicians involved in the care of health care personnel (HCP) with occupational exposure to HIV. . , . prodrug. of . temsavir. . (attachment inhibitor). AI438011 Study. TAF (TFV . prodrug. ). Study 292-0102. Study 299-0102. Doravirine (non nucleoside reverse transcriptase inhibitor). MK1439007 Study. Module 2: Supporting Behavior Change Learning Objectives Understand key counseling techniques Learn and apply motivational interviewing tools to adherence counseling Outline Key Counseling Techniques , . prodrug. of . temsavir. . (. attachment inhibitor). AI438011 Study. TAF (TFV . prodrug. ). Study 292-0102. Study 299-0102. Doravirine (non nucleoside reverse transcriptase inhibitor). MK1439007 Study. 1 J i v i n g w i t h S c i e n c e C D 1 E n g l i s h S c r i p t Knock knock MaThemba : Yes, who is that? Thandi : Hello Ma, it is me Thandi from the Africa Centre (AC). MaThemba : Yes, How can P. olicy. Jessica Burry. HIV/HCV Pharmacist. July 2017. MSF . and Access to Medicines. Médecins Sans Frontières (MSF). , founded in 1971, is an international, independent, medical humanitarian organization that delivers emergency aid to people affected by armed conflict, epidemics, natural disasters and exclusion from healthcare in nearly 70 countries. . Adherence. Counseling. Flipchart. Adults, non-pregnant. nor breastfeeding. The mark “CDC” is owned by the US Dept. of Health and Human Services and is used with permission. Use of this logo is not an endorsement by HHS or CDC of any particular product, service, or enterprise.. Scientific Workshop. Improving patient care through better management of HIV Drug Drug Interactions: an interactive case workshop exploring key clinical challenges in both Sub-Saharan Africa and Europe.